Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
330
datasets available to search
ShareScore release 0.9.0
Dataset results
330 results for “anticancer”
Figure 3 from: Yusuf H, Kamarlis RK, Yusni Y, Fahriani M (2021) The anticancer activity of ethanol extract of Chromolaena odorata leaves in 7,12-Dimethylbenz[a]anthracene in (DMBA) induced breast cancer Wistar rats (Rattus novergicus). Pharmacia 68(2): 493-499. https://doi.org/10.3897/pharmacia.68.e63956
Figure 3 The means of nodules weight observed on week 16th.
Figure 1 from: Abbas AH, Mahmood AAR, Tahtamouni LH, Al-Mazaydeh ZA, Rammaha MS, Alsoubani F, Al-bayati RI (2021) A novel derivative of picolinic acid induces endoplasmic reticulum stress-mediated apoptosis in human non-small cell lung cancer cells: synthesis, docking study, and anticancer activity. Pharmacia 68(3): 679-692. https://doi.org/10.3897/pharmacia.68.e70654
Figure 1 Synthesis of the target compounds (4–7).
Humoral Effect of SARS-CoV-2 mRNA vaccination with booster dose in solid tumor patients with different anticancer treatments
<p>Cancer patients are at risk for serious complications in case of SARS-CoV-2 infection. In these patients SARS-CoV-2 vaccination is strongly recommended, with the preferential use of mRNA vaccines. The antibody response in cancer patients is variable, depending on the type of cancer and antitumoral treatments. In solid tumor patients an antibody response similar to healthy subjects has been confirmed after the second dose. Only few studies explored the duration of immunization after the two doses and the effect of the third dose. In our study we explored a cohort of 273 solid tumor patients at different stages and treated with different anticancer therapies. Our analysis demonstrated that the persistence of the neutralizing antibody and the humoral response after the booster dose of vaccine was not dependent on either the tumor type, the stage or type of anticancer treatment.</p>
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
ClinicalTrials.gov study NCT06157892. IPD Sharing: YES. Countries: 9. Publications: 0.
Efficacy Study of Cosmetic Product on Xerosis Induced by Systemic Anticancer Treatments
ClinicalTrials.gov study NCT04181177. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety Evaluation of Autologous Dendritic Cell Anticancer Immune Cell Therapy (Cellgram-DC)
ClinicalTrials.gov study NCT04614051. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer
ClinicalTrials.gov study NCT01079481. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of an Oral Nutritional Supplement on Muscle Mass During Anticancer Treatment
ClinicalTrials.gov study NCT05648955. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
ClinicalTrials.gov study NCT05957367. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Mobile Health Intervention to Improve Adherence to Oral Anticancer Therapy
ClinicalTrials.gov study NCT07073807. IPD Sharing: NO. Countries: 1. Publications: 0.
Adjusting the Dose of Therapeutic Exercise to Prevent Neurotoxicity Due to Anticancer Treatment (ATENTO)
ClinicalTrials.gov study NCT04583124. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluating the Side Effects and How Well Anticancer Drugs Work in Very Young Patients With Cancer
ClinicalTrials.gov study NCT00897871. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers
ClinicalTrials.gov study NCT06800612. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Impact of a Multidisciplinary Consultation Program on Drug Adherence in First Oral Anticancer Treatment
ClinicalTrials.gov study NCT04797143. IPD Sharing: NO. Countries: 1. Publications: 0.
A First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 as Monotherapy and in Combination With Pembrolizumab or Other Anticancer Treatments in Participants With
ClinicalTrials.gov study NCT06877533. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT07109219. IPD Sharing: YES. Countries: 9. Publications: 0.
Long-term Follow-up and Quality of Life of Patients Treated With Anticancer Drugs
ClinicalTrials.gov study NCT06317714. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study on Drug-drug Interactions in Patients Treated With Anticancer Agents for a Prostate Cancer in Real Life Setting
ClinicalTrials.gov study NCT05612841. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors
ClinicalTrials.gov study NCT06364410. IPD Sharing: YES. Countries: 1. Publications: 0.
Impact of Aerobic Exercise on the Anticancer Immune Response in Patients Receiving Cancer Treatment
ClinicalTrials.gov study NCT06911970. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.